Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-11

Clinical Trial Update: Fluoxetine vs CBT in Childhood Anxiety Disorders [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fluoxetine with cognitive-behavioral therapy for childhood anxiety disorders; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: Children's Hospital Los Angeles | Conditions: Anxiety Disorders | Phase 3 | Status: ACTIVE_NOT_RECRUITING